Platelet Isoprostane Overproduction in Diabetic Patients Treated With Aspirin Full Text
Diabetes,  Clinical Article

Cangemi R et al. – The findings suggest that in aspirin–treated diabetic patients, oxidative stress–mediated platelet isoprostane overproduction is associated with enhanced platelet recruitment, an effect that mitigates aspirin–mediated TxA2 inhibition.

Methods
  • A cross–sectional study was performed comparing T2DM patients, treated (n = 50) or not treated (n = 50) with 100 mg/day aspirin, with 100 nondiabetic patients, matched for age, sex, atherosclerosis risk factors, and aspirin treatment.
  • A short–term (7 days) treatment with 100 mg/day aspirin also was performed in 36 aspirin–free diabetic and nondiabetic patients.

Results
  • Higher platelet recruitment, platelet isoprostane, and NOX2 activation was found in diabetic versus nondiabetic patients and in aspirin–treated diabetic patients versus nontreated patients (P < 0.001).
  • Platelet thromboxane (Tx) A2 (P < 0.001) was inhibited in all aspirin–treated patients.
  • In the interventional study, aspirin similarly inhibited platelet TxA2 in diabetic and nondiabetic patients (P < 0.001).
  • Platelet recruitment, isoprostane levels, and NOX2 activation showed a parallel increase in diabetic patients (P < 0.001) and no changes in nondiabetic patients.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Cardiology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Cardiology Articles

1 Beta-blockers in heart failure with preserved ejection fraction: A meta-analysis Heart Failure Reviews, July 28, 2014    Evidence Based Medicine    Review Article    Clinical Article

2 Egg consumption and cardiovascular disease among diabetic individuals: a systematic review of the literature Full Text Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, July 30, 2014    Free full text    Review Article

3 Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure Circulation: Heart Failure, July 24, 2014    Clinical Article

4 Statins in the elderly: an answered question Current Opinion in Cardiology, June 9, 2014    Evidence Based Medicine    Review Article    Clinical Article

5 Consumption of nuts and legumes and risk of stroke: a meta-analysis of prospective cohort studies Nutrition, Metabolism & Cardiovascular Diseases, July 25, 2014    Evidence Based Medicine    Clinical Article

6 Effects of six months of vitamin D supplementation in patients with heart failure: A randomized double-blind controlled trial Nutrition, Metabolism & Cardiovascular Diseases, May 2, 2014    Clinical Article

7 Long-term effect of antihypertensive drugs on the risk of new-onset atrial fibrillation: A longitudinal cohort study Hypertension Research, July 15, 2014    Clinical Article
Exclusive Author Commentary

8 Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: an updated meta-analysis International Journal of Cardiology, July 16, 2014    Evidence Based Medicine    Review Article    Clinical Article

9 HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative European Heart Journal, July 7, 2014    Evidence Based Medicine    Clinical Article

10 Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: Final five-year follow-up of the SYNTAX trial European Heart Journal, May 28, 2014    Clinical Article

11 Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: A randomized, placebo-controlled trial Full Text Nutrition Journal, November 15, 2013    Free full text    Clinical Article

12 Effect of resveratrol on blood pressure: A meta-analysis of randomized controlled trials Clinical Nutrition, July 22, 2014    Clinical Article

13 Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPROVE-IT study population American Heart Journal, July 29, 2014    Clinical Article

14 Comparison of 5-year survival after acute myocardial infarction using angiotensin-converting enzyme inhibitor versus angiotensin II receptor blocker The American Journal of Cardiology, June 13, 2014    Clinical Article

15 Cost-effectiveness of apixaban versus warfarin and aspirin in sweden for stroke prevention in patients with atrial fibrillation Thrombosis Research, July 3, 2014    Clinical Article

16 Treatment discontinuations with new oral agents for long-term anticoagulation: insights from a meta-analysis of 18 randomized trials including 101,801 patients Mayo Clinic Proceedings, July 23, 2014    Evidence Based Medicine    Clinical Article

17 Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms Heart, July 9, 2014    Evidence Based Medicine    Clinical Article

18 Effects of nebivolol versus metoprolol on sodium sensitivity and renal sodium handling in hypertensive Hispanic postmenopausal women Hypertension, July 14, 2014    Clinical Article

19 Efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: A systematic review and meta-analysis of phase III trials European Journal of Vascular and Endovascular Surgery, July 1, 2014    Review Article

20 Atenolol versus non-atenolol beta-blockers for the treatment of hypertension: a meta analysis Canadian Journal of Cardiology, February 10, 2014    Evidence Based Medicine    Review Article    Clinical Article

Indexed Journals in Cardiology: American Heart Journal, American Journal of Cardiology, Circulationn, Heartmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close